Plexus Announces Non-Cash Goodwill Impairment Charge of $5.7 Million
Posted on: Thursday, 16 April 2009, 06:00 CDT
Reaffirms Second Quarter Fiscal 2009 Guidance
Additionally, the Company has implemented further cost-cutting measures in response to the difficult economic environment and incurred restructuring costs of approximately
The Company also reaffirms second quarter fiscal 2009 guidance, with revenue expected to be within the previously announced revenue guidance of
About Plexus Corp. - The Product Realization Company
Plexus (www.plexus.com) is an award-winning participant in the Electronic Manufacturing Services (EMS) industry, providing product design, supply chain and materials management, manufacturing, test, fulfillment and aftermarket solutions to branded product companies in the Wireline/Networking, Wireless Infrastructure, Medical, Industrial/Commercial and Defense/Security/Aerospace market sectors.
The Company's unique Focused Factory manufacturing model and global supply chain solutions are strategically enhanced by value-added product design and engineering services. Plexus specializes in mid- to low-volume, higher-mix customer programs that require flexibility, scalability, technology and quality.
Plexus provides award-winning customer service to more than 100 branded product companies in
Safe Harbor and Fair Disclosure Statement
The statements contained in this release which are guidance or which are not historical facts (such as statements in the future tense and statements including "believe," "expect," "intend," "plan," "anticipate," "goal," "target" and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These factors include the risks that new program wins may not result in the expected revenues and profitability or result in long-term customer arrangements, and that the restructuring charges may be insufficient, depending upon future developments. In addition, other risks and uncertainties affecting our business and our ability to grow and prosper in the future include, but are not limited to: the economic performance of the electronics, technology and defense industries; the risk of customer delays, changes or cancellations in both ongoing and new programs; the poor visibility of future orders, particularly in view of current economic conditions; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers and maintain our current customer base and deliver product on a timely basis; the risks relative to new customers, including a new confidential customer in the Industrial/Commercial sector, which risks include customer delays, start-up costs, our potential inability to execute and lack of a track record of order volume and timing; the risks of concentration of work for certain customers; the weakness of the global economy and the continuing instability of the global financial markets and banking system, including the potential inability on our part or that of our customers or suppliers to access cash investments and credit facilities; material cost fluctuations and the adequate availability of components and related parts for production; the effect of changes in average selling prices; the effect of start-up costs of new programs and facilities, including our recent and planned expansions, such as our new facility in Oradea,
SOURCE Plexus Corp.
Source: PR Newswire
Related Articles
- Escalon(R) Reports Fourth Quarter and Fiscal 2009 Results
- iPharro and Atex are Latest Members of Signiant Integration Product Program
- OmniVision Reports Financial Results for Fourth Quarter and Fiscal 2009
- California Micro Devices Reports March Quarter and Fiscal 2009 Results
- Accuray Announces Results for Third Quarter of Fiscal 2009
- Signiant Integration Product Program Benefits Customers Looking to Expand Signiant's Functionality and Usefulness
- The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates
- Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2009
- Sun Microsystems Reports Preliminary Results for the First Quarter Fiscal Year 2009
- Abiomed Announces 16% Revenue Growth to $16.4 Million for First Quarter of Fiscal 2009
User Comments (0)

RSS Feeds